News
-
Aptamer Group launches a £3.6 million fundraising
August 2023
-
Eden Research launches fundraise for up to £11 million to fund materials to build up stocks for its new seed treatment
August 2023
-
Scheme document published for the £16.7 million recommended cash acquisition of Yourgene Health by Novacyt
July 2023
-
Bivictrix Therapeutics raises £2.1 million via a Placing and Subscription
July 2023
-
Perivan attend the London Stock Exchange Marketplace Summer Networking Drinks
July 2023
-
Perivan's Annual Report client portfolio has surpassed 300
July 2023
-
Deltex completes £1.7 million fundraise and launches retail offer
July 2023
-
Perivan to exhibit at Sifted Summit 2023
July 2023
-
Offer document published for the recommended £45.3 million cash offer by Globe Invest for Best of the Best
July 2023
-
Chariot to raise £12.5 million via a Placing, Subscription and Open Offer
July 2023
-
Pittards launch Proposed Management Subscriptions and Open Offer to raise up to £1.85 million
July 2023
-
Perivan attend the IoD Finance and FinTech & Insurance Groups summer business networking Party
July 2023
-
Quadrise launches up to £3.25 million fundraise to advance projects and strengthen balance sheet
July 2023
-
Perivan adds a further 54 new Annual Report clients to portfolio during the last 12 months
July 2023
-
All Things Considered Group successfully raises £4.18 million via a Placing and Subscription
July 2023
-
Perivan welcomes R&Q Insurance Holdings to our Annual Report portfolio
July 2023
